Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8701 - 8725 of 10781 in total

Tidutamab

Tidutamab is under investigation in clinical trial NCT04590781 (Safety and Efficacy of Xmab18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer).
Investigational

2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE

Experimental
Matched Name: … 2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE …
Matched Iupac: … 2-(2-methylphenyl)-1H-indole-5-carboximidamide …

2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol

Experimental
Matched Name: … 2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol …
Matched Iupac: … 2,6-dimethyl-4-[(1E)-2-phenylethenyl]phenol …

Veliparib

Investigational
Matched Synonyms: … 2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide ... 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide …

Livmoniplimab

Livmoniplimab is under investigation in clinical trial NCT06109272 (A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)).
Investigational
Matched Synonyms: … anti-(human protein garp-transforming growth factor .beta.1 complex) (human monoclonal abbv-151 .gamma.4- …

N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide

Experimental
Matched Name: … N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide …
Matched Iupac: … (2S)-6-amino-N-(2-cyclohexylethyl)-2-[(2S)-3-hydroxy-2-(2-{4-[4-(2-methyl-1H-imidazol-1-yl)butyl]phenyl …

N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE

Experimental
Matched Name: … N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE …
Matched Iupac: … (2S)-N-(2-aminoethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4'-sulfamoyl-[1,1'-biphenyl]-4-yl}ethyl]amino …

bis(4-nitrophenyl) hydrogen phosphate

Experimental
Matched Name: … bis(4-nitrophenyl) hydrogen phosphate …
Matched Iupac: … bis(4-nitrophenoxy)phosphinic acid …

7,8-dihydroxy-4-phenyl-2H-chromen-2-one

Experimental
Matched Name: … 7,8-dihydroxy-4-phenyl-2H-chromen-2-one …
Matched Iupac: … 7,8-dihydroxy-4-phenyl-2H-chromen-2-one …

2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID

Experimental
Matched Name: … 2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID …
Matched Iupac: … 2-[(4-chlorophenyl)amino]pyridine-3-carboxylic acid …

Lirentelimab

Lirentelimab is under investigation in clinical trial NCT04856891 (A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis).
Investigational

Velafermin

Velafermin was a novel investigational protein therapeutic, also known as fibroblast growth factor-20 (FGF-20), which promotes both epithelial and mesenchymal cell proliferation in vitro and has demonstrated activity in multiple animal models. Velafermin was investigated as a potential therapy for the prevention and treatment of oral mucositis by fostering the...
Investigational

N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide

Experimental

Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone

Experimental
Matched Name: … Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone …
Matched Iupac: … {azaniumyl[2-(6-carbamimidoyl-1H-1,3-benzodiazole-2-carbonyl)-1H-1,3-benzodiazol-5-yl]methylidene}azanium …

Allogeneic ABCB5-positive limbal stem cells

Investigational

Phosphoramidon

Experimental
Matched Iupac: … methylpentanamido]-3-(1H-indol-3-yl)propanoic acid ... 2S)-2-[(2S)-2-{[hydroxy({[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phosphoryl]amino}-4- …

Methoserpidine

Experimental

N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide

Experimental
Matched Name: … N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide …
Matched Iupac: … N-[(2-fluorophenyl)methyl]-4-sulfamoylbenzamide …

4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose

Experimental

1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine

Experimental
Matched Name: … 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine …
Matched Iupac: … N''-[4-(2-oxo-2-phenylethyl)phenyl]guanidine …

1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID

Experimental
Matched Name: … 1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID …
Matched Iupac: … 1-phenyl-1H-pyrazole-4-carboxylic acid …

Pradofloxacin

Pradofloxacin is a 3rd generation fluoroquinolone antibiotic developed by Bayer HealthCare AG, Animal Health GmBH. It was approved by the European Commission in April 2011 for bacterial infections in dogs and cats.
Vet approved
Matched Iupac: … -3-carboxylic acid ... 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline …

Oxidized coenzyme A

Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-[(2-{[2-(hydroxysulfanyl ... )ethyl]carbamoyl}ethyl)carbamoyl]-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl …

EM-1745

Experimental
Matched Iupac: … [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 9-[(1S,2S,3aS,3bR,9bS,11aS)- …

Dexloxiglumide

Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued. As the D-isomer of loxiglumide, it retains all pharmacological properties of loxiglumide but is more potent.
Investigational
Matched Iupac: … (4R)-4-[(3,4-dichlorophenyl)formamido]-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid …
Displaying drugs 8701 - 8725 of 10781 in total